Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William A. Day is active.

Publication


Featured researches published by William A. Day.


Journal of Organic Chemistry | 1977

Cannabinoids. 3. Synthetic approaches to 9-ketocannabinoids. Total synthesis of nabilone.

Robert A. Archer; W. B. Blanchard; William A. Day; Douglas W. Johnson; Edward Ralph Lavagnino; C. W. Ryan; Jack E. Baldwin

Aufgrund des klinischen Interesses von Nabilon (VIa) werden verschiedene Synthesen zur Herstellung dieser Verbindung beschrieben, die an bekannte Verfahren anschliesen.


Biochemical Pharmacology | 1974

Comparison of the oxime and the hydroxylamine derivatives of 4-chloroamphetamine as depletors of brain 5-hydroxyindoles

Ray W. Fuller; Kenneth W. Perry; John C. Baker; C. John Parli; Nancy Wang Lee; William A. Day; Bryan B. Molloy

Brain 5-hydroxyindole levels were measured 6 hr after the i.p. injection of 4-chloroamphetamine and two of its possible metabolites—the oxime and the hydroxylamine. Both 4-chloroamphetamine and N-hydroxy-4-chloroamphetamine at 0·1 m-mole/kg caused marked reduction of serotonin and of 5-hydroxyindoleacetic acid levels, whereas the oxime had only a slight effect on serotonin levels. The N-hydroxy derivative appeared to be almost completely reduced to 4-chloroamphetamine in vivo, for it produced brain levels of 4-chloroamphetamine equivalent to those produced by 4-chloroamphetamine itself and lowered brain 5-hydroxyindole levels as much as did 4-chloroamphetamine at three different dose levels. Our results make it seem unlikely that 4-chloroamphetamines depletion of brain serotonin and 5-hydroxyindoleacetic acid is mediated by the conversion of 4-chloroamphetamine to these metabolites.


Archive | 1978

9-Amino-dibenzopyrans

William A. Day; Edward Ralph Lavagnino


Archive | 1979

Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor

Robert A. Archer; William A. Day


Journal of Medicinal Chemistry | 1973

Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 1. Structure-activity relationships.

Ray W. Fuller; Bryan B. Molloy; William A. Day; Betty W. Roush; Max M. Marsh


Journal of Medicinal Chemistry | 1975

Norepinephrine N-methyltransferase inhibition by benzamidines, phenylacetamidines, benzylguanidines, and phenylethylguanidines.

Ray W. Fuller; Betty W. Roush; Harold D. Snoddy; William A. Day; Bryan B. Molloy


Archive | 1976

Preparation of optically active trans-hexahydrodibenzopyranones

Robert A. Archer; William A. Day


Archive | 1977

Process for preparing dl-cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H -dibenzo[b,d]pyran-9-ones

William A. Day; Edward Ralph Lavagnino


Archive | 1979

9-AMINO- ET IMINO-DIBENZOPYRANNES ET LEUR UTILISATION THERAPEUTIQUE

William A. Day; Edward Ralph Lavagnino


Archive | 1979

Amino-dibenzopyrans, their preparation, formulations containing them and their use as pharmaceuticals

William A. Day; Edward Ralph Lavagnino

Collaboration


Dive into the William A. Day's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge